Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Ameliorative effects of melatonin on radiotherapy-induced apoptotic and inflammatory responses in rat parotid gland

Hacımustafaoğlu F., Aras S., Erzurumlu Y., Çaykara Peran B.

Animal Study on Chronic Inflammation, published in BMC Oral Health (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
BMC Oral Health (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41736025
PMCID
PMC13041126
DOI
10.1186/s12903-026-07966-8

Abstract (original English)

Background Radiotherapy-induced parotid gland injury is a major contributor to salivary hypofunction and xerostomia in head-and-neck cancer management. This study aimed to evaluate the differential radiobiological effects of flattening filter (FF) and flattening filter-free (FFF) 6 MV photon beams, delivered as single-dose or fractionated-dose regimens, on apoptotic, inflammatory, and angiogenic gene expression in rat parotid tissue, and to assess the potential radioprotective action of melatonin. Methods Female Sprague-Dawley rats (8-10 weeks old) were randomized into ten groups and irradiated with either a single 16 Gy dose or a fractionated-dose protocol (6.4 Gy × 5) using FF or FFF beams. Melatonin (10 mg/kg, intraperitoneally) was administered 15 min before irradiation. Parotid glands were collected 10 days post-irradiation, and mRNA expression levels of Bax, Bid, Casp3, Bcl2, Bcl2l1, Il1b, Tnf, and Vegfa were quantified by RT-qPCR. Results Irradiation significantly upregulated pro-apoptotic (Bax, Bid, Casp3) and pro-inflammatory (Il1b, Tnf) transcripts, along with Vegfa, while downregulating anti-apoptotic markers (Bcl2, Bcl2l1). These molecular alterations were more pronounced following FFF-beam and fractionated-dose. Melatonin pretreatment markedly attenuated radiation-induced gene expression changes, restored Bcl2 and Bcl2l1 levels, and normalized the Bcl2/Bcl2l1 ratio

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Parotid GlandAnimalsRatsRats, Sprague-DawleyRadiation Injuries, ExperimentalInflammationMelatoninVascular Endothelial Growth Factor ATumor Necrosis Factor-alphaProto-Oncogene Proteins c-bcl-2

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research